Clinical Trial

Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 27, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will assess the durability of protection of a single immunisation with the Genetically Attenuated Parasite 2 (GA2) against controlled human malaria infection by rechallenging previously immunised and protected participants from the CoGA study (NCT05468606)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-27.
Trial Details
NCT Number NCT06293339
Lead Sponsor Leiden University Medical Center
Conditions Malaria,Falciparum
Enrollment 14 participants
Start Date 2025-03-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-27